tirzepatide press release FDA Approves Tirzepatide, A Potential Blockbuster Drug for Type 2 Diabetes Tirzepatide Telehealth Stock Crashes on

Clinical trials demonstrate that the dual-receptor approach produces greater fat loss than single-agent GLP-1 therapy alone

[3] [4] Clinical trials have established a well-characterised side effect profile for Wegovy, with the majority of adverse effects relating to the gastrointestinal system

Semaglutide helps manage diabetes by stimulating insulin secretion in response to meals, reducing glucagon release, and slowing gastric emptying, which helps control blood sugar levels

Hormonal Adaptations and Weight Trajectory LSG removes ~ 80% of the stomach, including the fundus (a major site of ghrelin production and gastric reservoir function)

Drugs like Ozempic and Mounjaro were created and approved for type 2 diabetes management